3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Multiple Myeloma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Paraproteinemias
1
Neoplasms, Plasma Cell
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
pembrolizumab
34
Cisplatin
30
Brachytherapy
16
Paclitaxel
15
Carboplatin
15
Bevacizumab
15
Radiotherapy
14
Blood Specimen Collection
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
11
Colposcopy
11
Nivolumab
10
Drug Therapy
10
atezolizumab
8
Human Papillomavirus DNA Tests
8
Gemcitabine
8
lenvatinib
7
Radiation
6
Platinum
6
Biopsy
6
toripalimab
5
cemiplimab
5
Surveys and Questionnaires
5
Standard of Care
5
Radiotherapy, Intensity-Modulated
5
Practice Guidelines as Topic
5
Patient Navigation
5
Methods
5
Fulvestrant
5
Fluorodeoxyglucose F18
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Chromatin Immunoprecipitation Sequencing
×
1 year
×
Clear all
NCT04723095
2026-03-05
NeCTuR
M.D. Anderson Cancer Center
Recruiting
750 enrolled